US EditionHer research revealed a safety concern with a vaccine. Then the NIH pulled her funding
- On March 10, Dr. Nisha Acharya received a letter from the National Institutes of Health terminating her grant to study the safety and effectiveness of a vaccine recommended for adults 50 and older in the US.
- The grant was canceled due to a change in NIH policy, which now prioritizes other research activities over those focused on vaccine hesitancy and improving vaccine interest, following Robert F. Kennedy Jr.'s appointment as head of the US Department of Health and Human Services.
- Dr. Acharya, a clinician scientist and ophthalmologist at the University of California at San Francisco, was using the almost $2 million grant, which covered 35% of her salary, to study questions related to the Shingrix vaccine and its potential link to the reawakening of the virus in the eyes, a concern among ophthalmologists.
- Acharya stated that she doesn't have a way of continuing this work, while an HHS official stated, regarding the grant terminations, that they will leave no stone unturned in identifying the root causes of the chronic disease epidemic, as part of their mission to Make America Healthy Again.
- As a result of the grant cancellation, which wipes out over three years of funding, Acharya plans to lay off three full-time employees who were analyzing data related to the vaccine, and she intends to appeal the decision, as many universities are coping with similar grant cancellations.
19 Articles
19 Articles
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
Saint Herblain (France), March 31, 2025 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) to potentially expand the use of its chikungunya vaccine, IXCHIQ®, currently approved in adults1, to adolescents aged 12 to 17 years in the UK. This submission follows the recent p…
Her research revealed a safety concern with a vaccine. Then the NIH pulled her funding
On March 10, Dr. Nisha Acharya got a letter from the National Institutes of Health terminating her grant to study the safety and effectiveness of a vaccine recommended for all adults in the US who are over the age of 50.
union-bulletin.com
Lancaster FarmingVaccine and COVID research, LGBTQ studies among NC projects hit by NIH cuts
Nearly two dozen grants and millions in research dollars have been canceled at UNC-Chapel Hill, Duke University and other North Carolina institutions as part of the growing list of projects cut by the National Institutes of Health.
Coverage Details
Bias Distribution
- 92% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
